Synthesis, crystal structure and fluorescent sensing property of metal–organic frameworks with 1,3-di(1H-imidazol-4-yl)benzene and 1,4-phenylenediacetate
-
Add time:07/22/2019 Source:sciencedirect.com
In this work, two new metal–organic frameworks (MOFs) based on 1,3-di(1H-imidazol-4-yl)benzene (L) and 1,4-phenylenediacetic acid (H2pda), namely [Ni(L)(pda)(H2O)] (1) and [Cd(L)(pda)] (2), have been achieved. MOFs 1 and 2 have distinct infinite one-dimensional (1D) chain structures, which are further linked together by hydrogen bonding interactions to give the eventual three-dimensional (3D) supramolecular architectures. Photoluminescence studies revealed that the Cd(II) MOF 2 shows strong emission at 346 nm upon excitation at 308 nm at room temperature. Furthermore, 2 can efficiently detecting acetone molecules, and Fe3+ and Cr2O72− ions via fluorescent quenching.
We also recommend Trading Suppliers and Manufacturers of 4-(1H-IMIDAZOL-4-YL)-1-METHYL-PIPERIDINE (cas 106243-44-1). Pls Click Website Link as below: cas 106243-44-1 suppliers
Prev:A facile synthesis and microtubule-destabilizing properties of 4-(1H-benzo[d]imidazol-2-yl)-furazan-3-amines
Next:Selectively sensing and adsorption properties of nickel(II) and cadmium(II) architectures with rigid 1H-imidazol-4-yl containing ligands and 1,3,5-tri(4-carboxyphenyl)benzene) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis and characterization of d10 metal complexes with mixed 1,3-di(1H-imidazol-4-yl)benzene and multicarboxylate ligands07/26/2019
- Synthesis, spectral investigation, molecular docking and biological evaluation of Cu(II), Ni(II) and Mn(II) complexes of (E)-2-((2-butyl-4-chloro-1H-imidazol-5-yl)methylene)-N-methylhydrazinecarbothioamide (C10H16N5ClS) and its DFT studies07/25/2019
- Mediated luminescent properties of salts with 4-((1H-imidazol-1-yl)methyl)benzonitrile: Syntheses, crystal structures and properties07/24/2019
- Selectively sensing and adsorption properties of nickel(II) and cadmium(II) architectures with rigid 1H-imidazol-4-yl containing ligands and 1,3,5-tri(4-carboxyphenyl)benzene07/23/2019


